Piclozotan (SUN-N4057) is a selective 5-HT1A receptor partial agonist which has neuroprotective effects in animal studies. It has been through early clinical trials in humans for treatment of acute stroke but results have not yet been announced.
This page contains content from the copyrighted Wikipedia article "Piclozotan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.